Biologics

The global orthobiologics market is expected to grow to nearly $8 billion by 2016, according to projections from Transparency Market Research.

Sean McMillan, DO, became the first surgeon to use the Bear anterior cruciate ligament implant in New Jersey, ROI-NJ reported Feb. 3.

The California Institute of Regenerative Medicine has provided a $1.3 million grant to Kevin Stone, MD, chair of the Stone Research Foundation, and Mani Vessal, PhD, senior director of research and operation for the foundation, to advance a paste graft…

Timothy Scannell, former president and COO at Stryker, was added to the board of directors at Collagen Matrix.

Life sciences company BioRestorative Therapies has been named one of the 10 most innovative regenerative medicine companies in 2022 by Insights Care Magazine.

Bone Solutions, an orthopedic devicemaker, launched the Mg Osteoinject bone void filler.

More spine and orthopedic surgeons are bringing regenerative medicine to their practices. 

Researchers sought to examine the effectiveness of intradiscal biologics for treating discogenic low back pain and found low-quality evidence supporting it, according to a study published in the February 2022 edition of The Spine Journal.

Regenerative medicine in orthopedic surgery has remained an area of interest among Becker's readers in 2021.

Brian Domby, MD, of Florida Medical Clinic in Brandon, started using the MACI regenerative procedure for cartilage repair, the practice said Dec. 21.